Correlation Engine 2.0
Clear Search sequence regions


  • cordycepin (11)
  • humans (1)
  • mice (1)
  • rats (4)
  • Sizes of these terms reflect their relevance to your search.

    Although adenosine and its analogues have been assessed in the past as potential drug candidates due to the important role of adenosine in physiology, only little is known about their absorption following oral administration. In this work, we have studied the oral absorption and disposition pathways of cordycepin, an adenosine analogue. In vitro biopharmaceutical properties and in vivo oral absorption and disposition of cordycepin were assessed in rats. Despite the fact that numerous studies showed efficacy following oral dosing of cordycepin, we found that intact cordycepin was not absorbed following oral administration to rats. However, 3'-deoxyinosine, a metabolite of cordycepin previously considered to be inactive, was absorbed into the systemic blood circulation. Further investigation was performed to study the conversion of 3'-deoxyinosine to cordycepin 5'-triphosphate in vitro using macrophage-like RAW264.7 cells. It demonstrated that cordycepin 5'-triphosphate, the active metabolite of cordycepin, can be formed not only from cordycepin, but also from 3'-deoxyinosine. The novel nucleoside rescue metabolic pathway proposed in this study could be responsible for therapeutic effects of adenosine and other analogues of adenosine following oral administration. These findings may have importance in understanding the physiology and pathophysiology associated with adenosine, as well as drug discovery and development utilising adenosine analogues.

    Citation

    Jong Bong Lee, Masar Radhi, Elena Cipolla, Raj D Gandhi, Sarir Sarmad, Atheer Zgair, Tae Hwan Kim, Wanshan Feng, Chaolong Qin, Cecilia Adrower, Catherine A Ortori, David A Barrett, Leonid Kagan, Peter M Fischer, Cornelia H de Moor, Pavel Gershkovich. A novel nucleoside rescue metabolic pathway may be responsible for therapeutic effect of orally administered cordycepin. Scientific reports. 2019 Oct 31;9(1):15760

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 31673018

    View Full Text